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The role of mitochondria in ischemia/reperfusion injury
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The role of mitochondria in ischemia/reperfusion injury in
organ transplantation. In organ transplantation, ischemia/
reperfusion (I/R) results in damage that may affect cell via-
bility and lead to organ failure. I/R injury involves a complex
cascade of events, including loss of energy, derangement of the
ionic hemostasis, production of reactive oxygen species, and cell
death. In this context, mitochondria may be critical organelles,
since they undergo major changes that may contribute to the
injury occurring during I/R.
The damage of allografts derived from ischemia/
reperfusion (I/R) during transplantation may influence
short- and long-term graft function and outcome [1].
Key words: apoptosis, organ preservation, transplant.
Recently the shortage of organs has promoted the
transplantation of marginal allografts to try to expand
the donor pool. I/R may be an important determinant as
to whether marginal grafts survive or fail following trans-
plantation. I/R represent a potentially significant injury
in the process of transplantation and mitochondria play
a critical part, by their pivotal role in energy production,
by the generation of reactive oxygen species (ROS) and
the initiation of apoptosis.
PHYSIOLOGY
Mitochondria are organelles with two defined compart-
ments, the matrix confined with the inner mitochondrial
membrane and the intermembrane space surrounded
by the outer membrane. Mitochondria generate cellu-
lar energy in the form of adenosine triphosphate (ATP).
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This occurs predominantly through oxidative phospho-
rylation, in which electrons are passed along a series
of protein complexes situated in the inner mitochon-
drial membrane and which form the electron transport
chain (ETC). The hydrogen deriving from oxidation of
organic acids is oxidized with O2 to generate water. Elec-
trons generated from reduced nicotinamide adenine din-
ucleotide (NADH) are collected by complex I (NADH
dehydrogenase) and from succinate by complex II (succi-
nate dehydrogenase). Subsequently, electrons are passed
to complex III (cytochrome bc1) through coenzyme Q
(CoQ) and to complex VI [cytochrome c oxidase, (COX)
using cytochrome c as a carrier, and finally to O2 to form
water (Fig. 1A). The energy produced from the electron
flow is utilized to drive out protons (H+) at the level
of complexes I, III, and VI. As the inner mitochondrial
membrane is almost impermeable, an electrochemical
gradient is formed and is used to reintroduce protons
through the proton channel of complex V (ATP syn-
thase). The proton flow drives the condensation of adeno-
sine diphosphate (ADP) and inorganic phosphate to form
ATP. The ATP is exchanged with cytosolic ADP by ade-
nine nucleotide translocator (ANT) (Fig. 1A). Thus, the
maintenance of the electrochemical gradient is important
for O2 consumption by the ETC, which is coupled with
ADP phosphorylation by complex V (ATP synthase) [2].
Normally, mitochondria produce a small, but steady
amount, of ROS as by-products of respiration. Most of
the oxygen consumed by mitochondria is tetravalently re-
duced to water (by four electrons). A proportion of O2 is
univalently reduced (by single electrons) that leak along
the electron transport chain to form superoxide (O2•−).
Superoxide is converted by the mitochondrial superox-
ide dismutase (MnSOD) to hydrogen peroxide (H2O2)
and this in turn is reduced to water by peroxidase using
glutathione (GSH) as a substrate. Oxidized glutathione
(GSSG) is reduced with conversion of NADH to NAD
[3] (Fig. 2). Mitochondria also contain a nitric synthase
and can produce a significant amount of nitric oxide to
regulate their respiration [4]. The steady production of
small amounts of ROS is essential to maintain the “re-
dox state,” central for the activation of several genes,
Ca2+ cycling and for the function of numerous enzymes
[5, 6].
ISCHEMIA
Ischemia leads to alterations to the mitochondrial
ETC complexes and decreased efficacy of the antioxidant
system. Ischemic episodes of short duration increase the
electronegativity of the ETC complexes and leakage of
electrons. If the episode of ischemia is short then it may
not be sufficient to alter the antioxidant system in mito-
chondria and the ROS produced following reintroduction
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Fig. 1. Schematic illustration of mitochondrial oxidative phosphoryla-
tion under physiologic conditions (A) and the major changes during
ischemia (B) and reperfusion (C). The oxidative phosphorylation takes
place within the mitochondrial inner membrane through complexes of
the electron transport chain (complexes I to IV), complex V [adenosine
triphosphate (ATP) synthase], and the adenine nucleotide translocator
(ANT). Under normal conditions, most of the O2 is reduced at the level
of complex IV [cytochrome c oxidase (COX)]. Small amount of O2 is
reduced to superoxide by single electrons that leak from the electron
transport chain. For more details see the test. Abbreviations are: CoQ,
coenzyme Q; Cyt c, cytochrome C; ADP, adenosine diphosphate; Pi, in-
organic phosphate; MnSOD, manganese superoxide dismutase; GSH,
glutathione-stimulating hormone
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Fig. 2. Reactive oxygen species (ROS) production and mitochondrial
antioxidant system. For details see test. Abbreviations are: MnSOD,
manganese superoxide dismutase; NADP, nicotinamide adenine din-
ucleotide phosphate; NADPH, reduced nicotinamide adenine dinu-
cleotide phosphate; GSH, glutathione-stimulating hormone; GSSG,
oxidized glutathione.
of O2 are scavenged. Under certain circumstances, such
as ischemic preconditioning, the production of ROS in
mitochondria following a brief period of ischemia and
reperfusion may be essential in providing cell protection.
Mitochondrial ROS produced during ischemic precondi-
tioning, together with other chemical signals such as nitric
oxide, trigger a complex cascade of signaling events that
culminate in the synthesis of proteins, such as MnSOD
and inducible nitric oxice, which are essential in confer-
ring tissue protection (reviewed in [7]).
When the ischemic period is prolonged, more pro-
found changes within the mitochondria occur. Extended
ischemia time may result in decreased activity of the com-
plexes of the electron transport chain such as complex IV
and complex I [8]. This would impair the ETC and re-
sult in decreased ATP production following reperfusion.
Impairment of the ETC complexes also leads to elec-
tron leak and to the reduction of O2 by single electrons
following reperfusion with the formation of superoxide
radicals [3, 5]. Furthermore, ETC is rich in proteins with
sulfur iron centers and the reduction of these proteins
during ischemia results in the liberation of ferrous iron
that can be important in mediating the formation of ROS
at reperfusion [9] (Fig. 2). In addition, ischemia affects the
mitochondrial antioxidant system by decreasing the activ-
ity of antioxidant enzymes, such as MnSOD [10] and/or
depleting substrates such as glutathione, which render
cells more susceptible to oxidative stress at reperfusion
[11].
The absence of O2 results in the stimulation of anaer-
obic metabolism with the break down of ATP to ADP
and adenonsine monophosphate (AMP) and the accu-
mulation of inorganic phosphate, which induces mem-
brane permeabilization [12]. Membrane permeability can
also be increased by Ca2+ accumulation in the mitochon-
drial matrix during the ischemic period [6]. Anerobic
metabolism during ischemia also results in the accumu-
lation of lactic acid and a decrease in mitochondrial pH,
but this appears to be a protective attempt to prevent cell
death [13].
REPERFUSION
Depending on its severity, reperfusion is characterized
by the increase formation of ROS, a decrease in ATP
production and cell death. The reintroduction of O2 at
reperfusion may lead to a significant production of ROS.
The overproduction of superoxide (O2•−) at reperfusion
in the presence of reduced of MnSOD activity may lead to
a reaction with nitric oxide to form peroxynitrite, a highly
reactive molecule, which leads to nitration of proteins,
oxidation of thiols or decomposition into hydroxyl radical
(OH•−) [3, 4, 6]. OH•− may also be formed through the
Fenton reaction from insufficient conversion of H2O2 to
water as results of the depletion of mitochondrial GSH
during ischemia [3, 5, 11] (Fig. 2).
ROS produced at reperfusion may also damage pro-
teins, lipids and DNA, which leads to further impairment
of mitochondrial function and also to cell death. Damage
to ETC proteins, such as complex I, leads to reduced ac-
tivity and further reduction of ATP levels [14]. Lipid dam-
age affects membrane permeability and further impairs
ATP production. Inner membrane permeability is also
affected by the oxidative stress that leads to alteration of
the “redox state” by the oxidation of pyridines and thi-
ols and with the modification of the NADH/NAD and
GSH/GSSG ratio [15]. Oxidative stress after I/R has also
been associated with mitochondrial DNA damage that
occurs following depletion of thiols such as glutathione in
isolated cells [16]. ROS may also interact and alter signal-
ing transduction that interferes with or initiates cell death
by apoptosis or necrosis [5]. During reoxygenation rapid
cell death may occur due to the rise in intramitochondrial
pH (13) or from Ca2+ released from mitochondria into
the cytosol leading to activation of proteases, nucleases
and phospholipases, which trigger apoptosis [6].
PERMEABILITY TRANSITION AND APOPTOSIS
Apoptosis or programmed cell death is a physiologic
cellular event aimed at controlled cell turnover and tissue
hemostasis. Increased cellular death by apoptosis in con-
ditions such as I/R may contribute to the development
of organ failure. Apoptosis is the result of activation of a
cascade of intracellular proteins (caspases), and is inhib-
ited by a certain number of proteins, including the Bcl-2
family. There is general agreement that mitochondria are
involved in apoptosis through increased permeability of
their membranes, a process described as permeability
transition [17].
The increased permeability of the inner mitochondrial
membrane can occur by the formation at the contact
site between the inner and outer membrane of nonspe-
cific pores named megachannels. These megachannels are
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thought to be formed by the interaction of adenine nu-
cleotide translocator (ATN), the voltage-dependent an-
ion channel voltage dependent anion channel (VDAC)
and other proteins, such as members of the Bcl-2 family
(Bax/Bcl-2) (reviewed in [18]). Opening of megachannels
allows small molecules and water to pass, which may re-
sult in matrix swelling and rupture of the mitochondrial
outer membrane [19]. The end result is the release of acti-
vating factors such as apoptosis inducing factor (AIF), cy-
tochrome c, and Smac/DIABLO, which normally are re-
tained in the mitochondrial inter-membrane space. Once
liberated into the cytosol these proteins induce apoptosis
either by contributing to caspase activation (in case of cy-
tochrome c) or in a caspase-independent manner [19, 20].
It has been demonstrated that permeability transition oc-
curs during I/R, triggered by conditions such as increased
production of ROS, depletion of antioxidants, alteration
of pyridine nucleotide ratios, oscillation of Ca2+ concen-
tration, and increase of inorganic phosphate in the matrix.
All these situations occur in mitochondria during I/R as
mentioned above.
CONCLUSION
Mitochondria undergo profound changes during I/R
that may significantly contribute to cell and organ injury.
Understanding the pathophysiology of these changes
may be helpful in designing therapeutic strategies to pro-
tect organs at the time of transplantation.
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